HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats.

Abstract
Implant related infection is one of the most feared and devastating complication associated with the use of orthopaedic implant devices. Development of anti-infective surfaces is the main strategy to prevent implant contamination, biofilm formation and implant related osteomyelitis. A second concern in orthopaedics is insufficient osseointegration of uncemented implant devices. Recently, we reported on a macroporous titanium-oxide surface (bioactive TiOB) which increases osseointegration and implant fixation. To combine enhanced osseointegration and antibacterial function, the TiOB surfaces were, in addition, modified with a gentamicin coating. A rat osteomyelitis model with bilateral placement of titanium alloy implants was employed to analyse the prophylactic effect of gentamicin-sodiumdodecylsulfate (SDS) and gentamicin-tannic acid coatings in vivo. 20 rats were randomly assigned to four groups: (A) titanium alloy; PBS inoculum (negative control), (B) titanium alloy, Staphylococcus aureus inoculum (positive control), (C) bioactive TiOB with gentamicin-SDS and (D) bioactive TiOB plus gentamicin-tannic acid coating. Contamination of implants, bacterial load of bone powder and radiographic as well as histological signs of implant-related osteomyelitis were evaluated after four weeks. Gentamicin-SDS coating prevented implant contamination in 10 of 10 tibiae and gentamicin-tannic acid coating in 9 of 10 tibiae (infection prophylaxis rate 100% and 90% of cases, respectively). In Group (D) one implant showed colonisation of bacteria (swab of entry point and roll-out test positive for S. aureus). The interobserver reliability showed no difference in the histologic and radiographic osteomyelitis scores. In both gentamicin coated groups, a significant reduction of the histological osteomyelitis score (geometric mean values: C = 0.111 ± 0.023; D = 0.056 ± 0.006) compared to the positive control group (B: 0.244 ± 0.015; p < 0.05) was observed. The radiographic osteomyelitis scores confirmed these histological findings.
AuthorsM Diefenbeck, C Schrader, F Gras, T Mückley, J Schmidt, S Zankovych, J Bossert, K D Jandt, A Völpel, B W Sigusch, H Schubert, S Bischoff, W Pfister, B Edel, M Faucon, U Finger
JournalBiomaterials (Biomaterials) Vol. 101 Pg. 156-64 (09 2016) ISSN: 1878-5905 [Electronic] Netherlands
PMID27294535 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • Alloys
  • Anti-Bacterial Agents
  • Coated Materials, Biocompatible
  • Gentamicins
  • titanium dioxide
  • Titanium
Topics
  • Alloys (therapeutic use)
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Bone and Bones (pathology)
  • Coated Materials, Biocompatible (therapeutic use)
  • Gentamicins (therapeutic use)
  • Male
  • Osseointegration
  • Osteomyelitis (etiology, pathology, prevention & control)
  • Prostheses and Implants (adverse effects)
  • Rats
  • Rats, Sprague-Dawley
  • Staphylococcal Infections (etiology, pathology, prevention & control)
  • Staphylococcus aureus (drug effects)
  • Titanium (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: